Evidera
Surayya Taranum, PhD, sMBA, CMPP, is a highly experienced senior medical writer currently with PPD, where responsibilities include scientific writing and medical communications. With a strong background in molecular biology and genetics, Taranum has previously held various leadership and advisory roles within the Healthcare Businesswomen’s Association, including Regional Director and Global Education Advisory Board Member. Contributions to industry sustainability efforts are evident through active participation in the European Medical Writers Association's sustainability group and as a guest editor for the EMWA Journal. Taranum's scientific writing journey spans roles at organizations such as 4Clinics and INSERM, with a PhD from the University of Cologne and prior degrees in animal sciences and genetics.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.